Completed enrollment in DENALI Part 2a; dose confirmation expected in 1H 2026DENALI Part 2 trial topline readout expected by year end 2026; potential to support accelerated approvalInitiation of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback